Texas Instruments Incorporated (TXN)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $277.42B
Last updated: Nov 17, 2026 at 11:06 AM ET
Texas Instruments Incorporated (TXN) Financials: Revenue, Profit and Cash Flow
Texas Instruments reported revenue of $17.68B for the fiscal year ended Dec 31, 2025, up 13.0% from the year before. That year, net income was $5.00B with a net margin of 28.3%, operating cash flow was $7.15B and free cash flow was $2.60B. The quarter ended Sep 30, 2026 had revenue of $6.05B and net income of $2.42B.
Revenue and Margins
The operating margin was 34.1% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $13.37B, a compound annual rate of 3.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $17.68B | +13.0% | 57.0% | 34.1% | 28.3% |
| Dec 2024 | $15.64B | -10.7% | 58.1% | 34.9% | 30.7% |
| Dec 2023 | $17.52B | -12.5% | 62.9% | 41.8% | 37.2% |
| Dec 2022 | $20.03B | +9.2% | 68.8% | 50.6% | 43.7% |
| Dec 2021 | $18.34B | +26.9% | 67.5% | 48.8% | 42.4% |
| Dec 2020 | $14.46B | +0.5% | 64.1% | 40.8% | 38.7% |
| Dec 2019 | $14.38B | -8.9% | 63.7% | 39.8% | 34.9% |
| Dec 2018 | $15.78B | +5.5% | 65.1% | 42.5% | 35.4% |
| Dec 2017 | $14.96B | +11.9% | 64.3% | 40.7% | 24.6% |
| Dec 2016 | $13.37B | N/A | 61.8% | 36.3% | 26.9% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 4.2% from the year before. In the quarter ended Sep 2026, net income rose 77.9% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.68B | $15.64B | $17.52B | $20.03B | $18.34B | $14.46B | $14.38B | $15.78B | $14.96B | $13.37B |
| Cost of revenue | $7.60B | $6.55B | $6.50B | $6.26B | $5.97B | $5.19B | $5.22B | $5.51B | $5.35B | $5.11B |
| Gross profit | $10.08B | $9.09B | $11.02B | $13.77B | $12.38B | $9.27B | $9.16B | $10.28B | $9.61B | $8.26B |
| Research and development | $2.08B | $1.96B | $1.86B | $1.67B | $1.55B | $1.53B | $1.54B | $1.56B | $1.51B | $1.36B |
| Operating income | $6.02B | $5.46B | $7.33B | $10.14B | $8.96B | $5.89B | $5.72B | $6.71B | $6.08B | $4.86B |
| Net income | $5.00B | $4.80B | $6.51B | $8.75B | $7.77B | $5.59B | $5.02B | $5.58B | $3.68B | $3.60B |
| EBITDA | $8.25B | $7.54B | $9.01B | $11.22B | $10.06B | $7.20B | $6.95B | $7.76B | $7.06B | $5.96B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.05B | $5.46B | $4.83B | $4.42B | $4.74B | $4.45B | $4.07B | $4.01B | $4.15B | $3.82B | $3.66B | $4.08B |
| Gross profit | $3.89B | $3.35B | $2.80B | $2.47B | $2.72B | $2.58B | $2.31B | $2.31B | $2.47B | $2.21B | $2.10B | $2.43B |
| Operating income | $2.87B | $2.31B | $1.81B | $1.47B | $1.66B | $1.56B | $1.32B | $1.38B | $1.55B | $1.25B | $1.29B | $1.53B |
| Net income | $2.42B | $1.98B | $1.54B | $1.16B | $1.36B | $1.29B | $1.18B | $1.21B | $1.36B | $1.13B | $1.10B | $1.37B |
Balance Sheet
As of Dec 2025, total debt of $14.05B exceeded cash and equivalents by $10.82B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $34.59B | $35.51B | $32.35B | $27.21B | $24.68B | $19.35B | $18.02B | $17.14B | $17.64B | $16.43B |
| Current assets | $13.75B | $15.03B | $15.12B | $14.02B | $13.69B | $10.24B | $8.76B | $8.10B | $8.73B | $7.46B |
| Cash and equivalents | $3.23B | $3.20B | $2.96B | $3.05B | $4.63B | $3.11B | $2.44B | $2.44B | $1.66B | $1.15B |
| Total liabilities | $18.31B | $18.61B | $15.45B | $12.63B | $11.34B | $10.16B | $9.11B | $8.14B | $7.30B | $5.96B |
| Short-term debt | $500.00M | $750.00M | $599.00M | $500.00M | $500.00M | $550.00M | $500.00M | $749.00M | $500.00M | $631.00M |
| Long-term debt | $13.55B | $12.85B | $10.62B | $8.23B | $7.24B | $6.25B | $5.30B | $4.32B | $3.58B | $2.98B |
| Shareholder equity | $16.27B | $16.90B | $16.90B | $14.58B | $13.33B | $9.19B | $8.91B | $8.99B | $10.34B | $10.47B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $36.84B | $35.88B | $34.39B | $34.59B | $35.00B | $34.93B | $33.76B | $35.51B | $35.32B | $35.05B | $34.88B | $32.35B |
| Total liabilities | $17.65B | $17.88B | $17.61B | $18.31B | $18.38B | $18.53B | $17.35B | $18.61B | $18.05B | $17.83B | $17.90B | $15.45B |
| Cash and equivalents | $4.21B | $3.66B | $3.55B | $3.23B | $3.31B | $3.04B | $2.76B | $3.20B | $2.59B | $2.74B | $2.48B | $2.96B |
| Shareholder equity | $19.18B | $18.01B | $16.78B | $16.27B | $16.63B | $16.40B | $16.41B | $16.90B | $17.27B | $17.21B | $16.98B | $16.90B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 36.4% of operating cash flow. Dividends and share repurchases together came to 249.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.15B | $6.32B | $6.42B | $8.72B | $8.76B | $6.14B | $6.65B | $7.19B | $5.36B | $4.61B |
| Capital expenditures | $4.55B | $4.82B | $5.07B | $2.80B | $2.46B | $649.00M | $847.00M | $1.13B | $695.00M | $531.00M |
| Free cash flow | $2.60B | $1.50B | $1.35B | $5.92B | $6.29B | $5.49B | $5.80B | $6.06B | $4.67B | $4.08B |
| Dividends paid | $5.00B | $4.79B | $4.56B | $4.30B | $3.89B | $3.43B | $3.01B | $2.56B | $2.10B | $1.65B |
| Share repurchases | $1.48B | $929.00M | $293.00M | $3.62B | $527.00M | $2.55B | $2.96B | $5.10B | $2.56B | $2.13B |
| Investing cash flow | -$1.44B | -$3.20B | -$4.36B | -$3.58B | -$4.09B | -$922.00M | -$1.92B | -$78.00M | -$1.13B | -$650.00M |
| Financing cash flow | -$5.69B | -$2.88B | -$2.14B | -$6.72B | -$3.14B | -$4.55B | -$4.73B | -$6.33B | -$3.73B | -$3.81B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.42B | $2.70B | $1.52B | $2.25B | $2.19B | $1.86B | $849.00M | $2.00B | $1.73B | $1.57B | $1.02B | $1.92B |
| Capital expenditures | $463.00M | $514.00M | $676.00M | $925.00M | $1.20B | $1.30B | $1.12B | $1.19B | $1.32B | $1.06B | $1.25B | $1.15B |
| Free cash flow | $2.96B | $2.19B | $844.00M | $1.33B | $993.00M | $555.00M | -$274.00M | $806.00M | $416.00M | $507.00M | -$231.00M | $776.00M |
Frequently Asked Questions About TXN
What is Texas Instruments' annual revenue?
Texas Instruments reported revenue of $17.68B for the fiscal year ended Dec 31, 2025.
How fast is Texas Instruments' revenue growing?
Revenue was up 13.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -4.1%.
Is Texas Instruments profitable?
Yes. Texas Instruments reported net income of $5.00B for the fiscal year ended Dec 31, 2025, with a net margin of 28.3%.
How much free cash flow does TXN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $7.15B minus capital expenditures of $4.55B produced free cash flow of $2.60B.
How much debt does Texas Instruments have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $13.55B, short-term debt of $500.00M and cash and equivalents of $3.23B.
TXN pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors